No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
PFE241213P17000
- 0.00
- 0.000.00%
15min DelayTrading Dec 11 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest17.00Strike Price0.00Turnover0.00%IV33.52%PremiumDec 13, 2024Expiry Date0.00Intrinsic Value100Multiplier2DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma--Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- Daily
No Data
News
Guggenheim Maintains Pfizer(PFE.US) With Buy Rating, Cuts Target Price to $33
Evercore Maintains Pfizer(PFE.US) With Buy Rating
Pfizer (PFE) Gets a Buy From Evercore ISI
NCCN Announces Funding for a Prostate Cancer Research Project
Express News | Pfizer : Leerink Partners Cuts Target Price to $28 From $31
REGISTRATION OPEN FOR THE 13th ANNUAL BUSINESS ARCHITECTURE INNOVATION SUMMIT